7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-09-30 2021-06-30 2021-03-31 
      
    		            
      cash flows from operating activities:
    		            
      consolidated net income
    		-6,516,000 -5,619,000 -12,622,000 -3,928,000 3,050,000 3,471,000 1,989,000 5,063,000 19,920,000 9,728,000 -5,171,000 9,583,000 
      adjustments to reconcile net income to net cash from operating activities:
    		            
      depreciation
    		20,980,000 20,819,000 20,272,000 19,538,000 19,620,000 18,829,000 19,090,000 23,914,000 22,498,000 25,365,000 26,667,000 26,217,000 
      amortization
    		20,675,000 23,206,000 23,619,000 23,385,000 23,473,000 24,198,000 24,135,000 23,761,000 23,358,000 22,527,000 22,556,000 18,399,000 
      remeasurement of tax receivable agreement
    		267,000           4,148,000 
      benefit from credit losses
    		-1,371,000 -81,000 2,045,000 -63,000 404,000 3,102,000 522,000      
      benefit from inventory obsolescence
    		945,000 8,000 588,000 340,000 789,000 175,000 291,000 243,000 325,000 313,000 694,000 1,532,000 
      non-cash share-based compensation expense
    		4,238,000 4,325,000 5,387,000 3,585,000 6,889,000 3,709,000 4,860,000 5,569,000 4,637,000 4,361,000 3,354,000 2,412,000 
      gain on sales and disposals of equipment
    		-279,000 98,000 -252,000 -426,000 -751,000 -308,000 -537,000 337,000 -593,000 -3,099,000 -193,000 -647,000 
      deferred income taxes
    		-6,767,000 -2,011,000 -3,310,000 -7,771,000 -4,229,000 4,657,000 -798,000 -6,965,000 4,398,000 7,346,000 762,000 3,932,000 
      changes in operating assets and liabilities:
    		            
      accounts receivable
    		-28,877,000 -2,450,000 5,233,000 3,384,000 -15,497,000 -7,396,000 12,253,000 -2,621,000 -6,212,000 -36,352,000 3,149,000 2,898,000 
      inventories
    		-12,467,000 5,394,000 -622,000 -5,920,000 -4,399,000 -5,649,000 -2,141,000 -3,426,000 -972,000 2,655,000 -5,055,000 3,641,000 
      other operating assets
    		5,431,000 -7,160,000 1,283,000 415,000 3,930,000 -2,578,000 -6,987,000 -1,711,000 1,132,000 -4,980,000 -638,000 226,000 
      accounts payable
    		7,386,000 -10,457,000 928,000 2,671,000 7,935,000 2,630,000 4,421,000 3,351,000 5,351,000 -651,000 3,991,000 1,361,000 
      accrued and other operating liabilities
    		10,117,000 -5,459,000 23,111,000 -12,132,000 13,682,000        
      net cash from operating activities
    		13,762,000 21,655,000 65,742,000 27,523,000 54,896,000 37,875,000 60,763,000 34,014,000 67,124,000 30,905,000 44,599,000 62,909,000 
      cash flows from investing activities:
    		            
      medical equipment purchases
    		-11,870,000 -16,158,000 -10,448,000 -13,384,000 -12,128,000 -18,370,000 -14,671,000 -12,818,000 -10,005,000 -7,643,000 -11,854,000 -4,415,000 
      property and office equipment purchases
    		-6,674,000 -9,151,000 -9,375,000 -8,970,000 -6,734,000 -11,226,000 -7,598,000 -7,561,000 -5,215,000 -4,927,000 -6,697,000 -3,915,000 
      proceeds from disposition of property and equipment
    		806,000 779,000 1,001,000 1,082,000 1,033,000 268,000 932,000 1,119,000 644,000 6,174,000 1,010,000 1,003,000 
      intangible asset purchases
    		-27,000            
      net cash from investing activities
    		-17,765,000 -25,969,000 -18,822,000 -21,272,000 -17,829,000 -88,562,000 -21,337,000 -22,385,000 -14,576,000 -6,396,000 -17,541,000 -457,525,000 
      cash flows from financing activities:
    		            
      proceeds under debt arrangements
    		70,000,000 36,000,000 58,000,000 1,121,937,000 87,000,000 40,000,000 0      
      payments under debt arrangements
    		-65,688,000 -38,688,000 -78,000,000 -1,122,200,000 -82,849,000 -13,850,000 -22,349,000      
      payments of principal under finance lease liability
    		-2,351,000 -2,460,000 -2,355,000 -2,390,000 -2,297,000 -2,136,000 -2,192,000 -2,261,000 -2,223,000 -2,451,000 -2,219,000 -2,051,000 
      payments of deferred financing costs
    		-871,000 -1,000 -89,000          
      payments under tax receivable agreement
    		-10,938,000 0 0 0 -24,822,000       -748,000 
      distributions to noncontrolling interests
    		-55,000 -66,000 -64,000 -50,000 -57,000 -54,000 -53,000 -15,000 -32,000 -55,000 -33,000 -50,000 
      proceeds from exercise of stock options
    		1,150,000 387,000 568,000 1,633,000 469,000 152,000 978,000      
      dividend and equity distribution payment
    		 0 0 0 -321,000 0 -2,000     -924,000 
      shares forfeited for taxes
    		-1,908,000 -9,000 -46,000 -932,000 -5,314,000 -59,000 -121,000      
      net cash from financing activities
    		-10,661,000 -6,035,000 -25,747,000 -11,491,000 -28,191,000 24,053,000 -23,739,000 -47,208,000 -74,770,000 -4,466,000 63,284,000 201,439,000 
      net change in cash and cash equivalents
    		-14,664,000 -10,349,000 21,173,000 -5,240,000 8,876,000 -26,634,000 15,687,000 -35,579,000 -22,222,000 20,043,000 90,342,000 -193,177,000 
      cash and cash equivalents at the beginning of period
    		20,037,000 0 0 0 5,577,000 0 0 0 74,325,000 0 0 206,505,000 
      cash and cash equivalents at the end of period
    		5,373,000 -10,349,000 21,173,000 -5,240,000 14,453,000 -26,634,000 15,687,000 -35,579,000 52,103,000 20,043,000 90,342,000 13,328,000 
      supplemental cash flow information:
    		            
      interest paid
    		22,050,000 21,914,000 8,725,000 15,723,000 14,622,000 12,559,000 11,050,000 9,641,000 9,523,000 9,974,000 11,271,000 19,746,000 
      income taxes paid
    		88,000 732,000 1,594,000 9,451,000 39,000 1,671,000 1,547,000   1,106,000   
      loss on extinguishment / modification of debt
    		 0 82,000          
      acquisitions, net of cash acquired
    		     -59,214,000 0     -450,198,000 
      proceeds from issuance of common stock
    		            
      purchases of treasury stock
    		 0           
      stock issuance costs
    		            
      acquisition holdback and contingent consideration
    		            
      the accompanying notes are an integral part of these consolidated financial statements.
    		            
      payments of contingent consideration
    		     0 0      
      loss on extinguishment of debt
    		     0 0      
      other operating liabilities
    		      3,665,000 -15,225,000 -6,691,000 2,947,000 -13,985,000 -10,811,000 
      benefit from credit (gains) losses
    		        -27,000    
      proceeds under revolver
    		            
      proceeds under term loan
    		            
      payments under term loan
    		            
      ​
    		            
      income taxes (refund) paid
    		        604,000   -715,000 
      remeasurement of tax receivable agreement and contingent consideration
    		            
      benefit from doubtful accounts
    		         548,000 555,000 18,000 
      payments under revolver
    		            
      change in book overdrafts
    		            
      proceeds under new revolver
    		           10,000,000 
      payments under new revolver
    		            
      proceeds under new term loan
    		           198,052,000 
      payments under new term loan
    		           -2,840,000 
      collection of note receivable from officer
    		            
      acquisition of agiliti health, inc. by thl shareholders
    		            
      payments under senior secured credit facility
    		            
      repayments of 2012 notes
    		            
      shares repurchased
    		            
      redemption of warrants
    		            
      contribution from new members to limited liability company
    		            
      intangible asset impairment charge
    		            
      gain on settlement
    		            
      amortization of intangibles, contract costs, deferred financing costs and bond premium
    		            
      interest on note receivable
    		            
      issuance of note receivable from officer
    		            
      acquisitions and refund of escrow
    		            
      proceeds under senior secured credit facility
    		            
      payments of principal under capital lease obligations
    		            
      payment of deferred financing costs
    		            
      holdback and earn-out payments related to acquisitions
    		            
      dividend and equity distribution payments
    		            
      proceeds from exercise of parent company stock options
    		            
      contribution from parent
    		            
      non-cash activities:
    		            
      medical equipment purchases included in accounts payable
    		            
      capital lease additions
    		            
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.